Buy Hylartin V Injection Online at Pet Well Global
Hylartin V Injection is a sterile veterinary injectable solution containing sodium hyaluronate 10 mg/mL. It is indicated for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis and is administered by intra-articular injection under the supervision of a licensed veterinarian.
At Pet Well Global, we supply genuine veterinary medicines sourced from trusted manufacturers. We proudly serve veterinarians, equine hospitals, horse owners, breeders, trainers, and equestrian professionals by providing authentic veterinary products supported by secure online ordering, competitive pricing, responsive customer service, and dependable worldwide shipping.
What Is Hylartin V Injection?
Hylartin V is a sterile, pyrogen-free solution of highly purified sodium hyaluronate, a naturally occurring component of healthy synovial fluid. According to the manufacturer’s prescribing information, each prefilled 2 mL syringe contains 20 mg of sodium hyaluronate (10 mg/mL). The product is intended exclusively for horses and is used to help restore normal joint function in cases of non-infectious synovitis associated with osteoarthritis.
Sodium hyaluronate helps improve the lubrication and viscoelastic properties of synovial fluid, supporting smoother joint movement and helping reduce discomfort associated with joint dysfunction.
Key Features
- Contains 10 mg/mL sodium hyaluronate
- Sterile intra-articular injection
- Designed specifically for horses
- Supports treatment of non-infectious synovitis associated with equine osteoarthritis
- Prefilled sterile syringe for convenient administration
- Prescription veterinary medicine
- Manufactured to high veterinary quality standards
- Secure online ordering
- Competitive pricing
- Fast USA and worldwide shipping
Why Buy from Pet Well Global?
Pet Well Global is committed to supplying genuine veterinary medicines from trusted manufacturers while providing a secure and convenient online shopping experience.
Benefits include:
- Genuine veterinary medicines
- Secure online checkout
- Competitive pricing
- Fast order processing
- Reliable worldwide shipping
- Responsive customer support
- Carefully packaged veterinary products
- Trusted equine healthcare brands
Veterinary Applications
According to the approved product labeling, Hylartin V is indicated for joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. The injection is administered directly into the affected joint by a licensed veterinarian. Depending on the affected joint and the veterinarian’s assessment, treatment protocols may include repeat administration when clinically appropriate. Treatment decisions should always be based on a complete orthopedic examination and veterinary diagnosis.
Product Quality
Pet Well Global sources veterinary medicines from reputable manufacturers committed to maintaining high standards of pharmaceutical quality, consistency, and product integrity. Every order is carefully packaged to help preserve product quality during storage and transportation.
Convenient Online Ordering
Shopping with Pet Well Global is quick, secure, and convenient. Browse our complete selection of equine veterinary medicines, complete your purchase using our encrypted checkout system, and enjoy dependable shipping to eligible destinations throughout the United States and internationally.
Shipping Information
Pet Well Global supplies veterinary medicines throughout the United States and many international destinations, including Canada, Australia, France, Germany, Spain, the Netherlands, Italy, Mexico, and many other eligible countries, subject to local veterinary medicine regulations and import requirements.
Storage Recommendations
Store Hylartin V Injection refrigerated at 2°C to 8°C (36°F to 46°F). Protect the product from freezing and light, and use only if the solution is clear and free from excessive air bubbles, in accordance with the manufacturer’s instructions.
Important Veterinary Information
Hylartin V Injection is for veterinary use only and should only be administered by or on the order of a licensed veterinarian. It is intended for intra-articular administration only and must not be administered intravascularly. The product is not for use in horses intended for human consumption. Always follow the manufacturer’s approved labeling and veterinary guidance.
Why Choose Pet Well Global?
Pet Well Global is committed to delivering trusted veterinary medicines, dependable customer support, and reliable worldwide shipping. Whether you manage a racing stable, breeding farm, veterinary practice, or performance horse facility, we strive to provide genuine veterinary healthcare products supported by secure ordering, competitive pricing, and professional service.
Frequently Asked Questions
What is Hylartin V Injection?
Hylartin V Injection is a sterile sodium hyaluronate injectable solution indicated for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis.
What is the active ingredient?
The active ingredient is sodium hyaluronate 10 mg/mL, with each 2 mL syringe containing 20 mg.
Which animals can receive Hylartin V Injection?
Hylartin V is indicated for horses only and should be administered by a licensed veterinarian.
Can I buy Hylartin V Injection online?
Availability depends on your country’s veterinary medicine regulations and any applicable prescription requirements.
Should I consult a veterinarian before using Hylartin V Injection?
Yes. Hylartin V is a prescription veterinary medicine and should only be administered under the supervision of a licensed veterinarian according to the approved product labeling.
Hylartin VÂ A sterile pyrogen-free solution of a highly purified, specific fraction of the sodium salt of hyaluronic acid extracted from rooster combs.
Description
Hylartin VÂ A sterile pyrogen-free solution of a highly purified, specific fraction of the sodium salt of hyaluronic acid extracted from rooster combs. Indicated in the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis.
- Sodium hyaluronate injection.
- Supplied in disposable glass syringes, contains 20mg (10mg/ml) of sodium hyaluronate in 2ml.
- Given to horses intra-articularly in small and medium size joints (carpal, fetlock). In the treatment of largers joints (hock), the dosage is 4ml (40mg). The treatment may be repeated at weekly intervals for a total of 3 treatments.
Undisputed Heavyweight Champion for Equine Lameness
HYLARTIN® V Injection (sodium hyaluronate) helps horses’ joints heal faster. It lubricates joint tissues, reduces friction, alleviates pain and improves joint action. HYLARTIN V is the heavyweight joint therapy champion, preferred by professionals who demand the most performance and protection available.
Hylartin V
This page contains information on Hylartin V for veterinary use.
The information provided typically includes the following:
- Hylartin V Indications
- Warnings and cautions for Hylartin V
- Direction and dosage information for Hylartin V
Hylartin V
This treatment applies to the following species:
- Horses
 Company: Zoetissodium hyaluronate injection
10 mg/mL
Product Information
Hylartin V Caution
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Description
HYLARTIN® V is a sterile pyrogen-free solution of a highly purified, specific fraction of the sodium salt of hyaluronic acid extracted from rooster combs. HYLARTIN® V is supplied in disposable glass syringes, each of which contains 20 mg (10 mg/mL) of sodium hyaluronate in 2.0 mL physiological sodium chloride-phosphate buffer with a pH of 7.0-7.5.
CHEMISTRY:
Sodium hyaluronate is a high molecular weight polymer made up of repeating disaccharide units of N-acetylglucosamine and sodium glucuronate linked by beta 1-3 and beta 1-4 glycosidic bonds. HYLARTIN® V contains only traces of protein.
Pharmacology
Sodium hyaluronate is a natural, physiological substance which occurs extracellularly in connective tissue in both animals and man and is chemically identical in different species. High concentrations (>0.2 mg/mL) of hyaluronate are found in the synovial fluid, the vitreous of the eye and the umbilical cord.
Sodium hyaluronate is a normal component of connective tissue matrix and it is injected therapeutically only in compartments where it constitutes a normal component, specifically the joint cavity.
ANIMAL SAFETY:
Acute, sub-acute and chronic toxicity studies in mice, rats, rabbits, dogs, monkeys and horses have not demonstrated any significant adverse reactions or sensitization.
In an acute toxicity study in horses, HYLARTIN® V was injected intra-articularly at dosages corresponding to five times the recommended dose per animal (200 mg total). In a sub-acute study, horses were injected intra-articularly with the recommended dose per joint (20 mg) at weekly intervals for nine weeks. The results of both investigations showed that hematological and blood chemistry values remained within normal ranges. In mice, the intravenous LD100 was found to be of the order of 50 mg/kg body weight.
There is always a potential immunological risk with repeated parenteral administration of biological material. However, as shown by Richter (1974), sodium hyaluronate, of both human and avian origin, did not produce any antibodies after repeated immunization, nor did intense stimulation of the immunization process by coupling of protein to the hyaluronate and simultaneous administration of Freund’s adjuvant give rise to antibodies.
CLINICAL STUDIES:
Clinical field trials with thoroughbred and standardbred race horses were undertaken at four separate clinics. A total of 252 joints were injected with HYLARTIN® V in these investigations. In one study, only horses which were conventional treatment failures were included and the overall improvement rate following HYLARTIN® V treatment approached 90 percent. In the other studies, the improvement rate surpassed this figure.
In another case, electrogoniometry
Reviews
There are no reviews yet.